DRG launches Market Access Disease Navigator

Healthcare research and data provider Decision Resources Group (DRG) has launched an oncology-focused product called Market Access Disease Navigator, which uses real world data to provide insight into patient populations, practitioners and payers.

DRG offers consultation and analysis enhanced by machine learning and AI; while providing access to experts in healthcare markets, disease areas and data science disciplines who offer a comprehensive view of patient access, and payer and health system dynamics. The firm's new Market Access Disease Navigator uses pharmacy and medical claims data from DRG's Real World Data Repository alongside local market expertise, to provide disease specific, account-level insights. These insights and data inform analysis of oncology patient populations, patient access to established and emerging therapies, and provider control over treatment decisions.

Senior Analyst Brandon Gee (pictured) comments: 'From shifts in hospital ownership and provider consolidation to considerations such as value-based payment models, purchasing behavior, and treatment cost, there is an urgent need to understand how these factors impact access to and utilization of therapies. Market Access Disease Navigator enables managed markets teams to better understand market access dynamics impacting oncology so users know how to focus tactical resources to make the biggest impact with contracting, reimbursement, account, marketing, and sales resources.'

Web site: www.decisionresourcesgroup.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.